Unirisco
Also known as Unirisco Galicia, S.C.R., S.A.
Galician venture capital company owned by the three Galician universities and regional companies; minority pre-seed and seed stakes in university spin-offs since 2001.
- HEADQUARTERS
- Santiago de Compostela, Spain
- FOUNDED
- 1998
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 3 people
Focus
- STAGES
- Pre-SeedSeed
- ASSET MIX
- Venture capitalImpact
- GEOGRAPHY
- Spain
Overview
Unirisco Galicia is a private venture capital company (SCR) promoted by the universities of Santiago de Compostela, A Coruña and Vigo together with Galician companies including Abanca, Inditex, Constructora San José, Estrella de Galicia, Gadisa, R Cable and Pescamar, plus Banco Santander. It takes temporary minority stakes in science- and technology-based spin-offs from Galician universities and research centres at pre-seed and seed stage, and says it has worked with more than 30 companies since 2001. Recent investments include Gazella Biotech (2024), Néboda (2025) and Batea Oncology (2025).
Investment thesis
Temporary minority investments in spin-offs born in the Galician university, technology and R&D ecosystem, at pre-seed and seed, under social-impact and return criteria.
PORTFOLIO (9)
- Batea OncologyHealthTech · since 2025
- NébodaFood & Agriculture · since 2025
- Gazella BiotechBiotech & Life Sciences · since 2024
- Diversa TechnologiesBiotech & Life Sciences
- InVerbisArtificial Intelligence
- OncostellaeBiotech & Life Sciences
- SitumSoftware & SaaS
- TastelabFood & Agriculture
- AppentraSoftware & SaaS
People
Links
Frequently asked questions
Unirisco is a VC fund based in Santiago de Compostela, Spain, founded in 1998.
Yes. Unirisco invests its own capital in private companies.
Unirisco invests at Pre-Seed and Seed stages in Biotech & Life Sciences, HealthTech, Software & SaaS and Food & Agriculture.
Key people at Unirisco include Inmaculada Rodríguez Cuervo (Managing Director (Directora general)), Pablo Mosquera Martínez (Investment Director) and Paulo González Alonso (Investment Analyst).
Unirisco's investments include Batea Oncology, Néboda, Gazella Biotech, Diversa Technologies, InVerbis, Oncostellae, Situm and Tastelab, among others.
The most recent publicly reported investment by Unirisco is Batea Oncology (Financing round with Xesgalicia), announced in Sep 2025.
Yes. Unirisco manages capital from outside investors.